Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic CentersTimothy Voorhees,Eric McLaughlin,Pallawi Torka,Jorge A Florindez,Tamara K. Moyo,Heather Reves,Nuttavut Sumransub,Saarang Deshpande,Ashley Rose,Cassandra Duarte,Muhammad Salman Faisal, Showkat Hamid,Suki Subbiah,Sabarish R. Ayyappan,Lauren Kelly Shea,Matthew J Cortese,Krish Patel,Ajay Major,Hayder Saeed,Jakub SvobodaBlood(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要